Cargando…
Embedding Dynamics in Intrinsic Physicochemical Profiles of Market-Stage Antibody-Based Biotherapeutics
[Image: see text] Adequate stability, manufacturability, and safety are crucial to bringing an antibody-based biotherapeutic to the market. Following the concept of holistic in silico developability, we introduce a physicochemical description of 91 market-stage antibody-based biotherapeutics based o...
Autores principales: | Licari, Giuseppe, Martin, Kyle P., Crames, Maureen, Mozdzierz, Joseph, Marlow, Michael S., Karow-Zwick, Anne R., Kumar, Sandeep, Bauer, Joschka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906779/ https://www.ncbi.nlm.nih.gov/pubmed/36573887 http://dx.doi.org/10.1021/acs.molpharmaceut.2c00838 |
Ejemplares similares
-
Intrinsic physicochemical profile of marketed antibody-based biotherapeutics
por: Ahmed, Lucky, et al.
Publicado: (2021) -
How can we discover developable antibody-based biotherapeutics?
por: Bauer, Joschka, et al.
Publicado: (2023) -
Trends in industrialization of biotherapeutics: a survey of product characteristics of 89 antibody-based biotherapeutics
por: Martin, Kyle P., et al.
Publicado: (2023) -
An adapted consensus protein design strategy for identifying globally optimal biotherapeutics
por: Liu, Yanyun, et al.
Publicado: (2022) -
Biomarkers for nonclinical infusion reactions in marketed biotherapeutics and considerations for study design
por: Mease, Kirsten M., et al.
Publicado: (2017)